维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="FASAN A"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Intact LFA-1 deactivation pro-motes T-cell activation and rejection of cardiac allograft显示文摘	Hiiser N Fasan A Semmrich M	2010	Int Immu-nol2010，22，1：	1
	2	NATURAL FREQUENCIES AND DAMPINGS IDENTIFICATION USING WA VELET TRANSFORM:APPLICATION TO REAL DATA显示文摘	Ruzzene M FasanaL A Garibald L		0，，02：	1
	3	EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial andneuro-ectodermal differentiation显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad Sci U S A2009，106，13：	1
	4	EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation显示文摘	Richter G H Plehm S Fasan A	2009	Proc Natl Acad Sci U S A2009，106，13：	1
	5	EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation 显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad Sci USA2009，106，：	1
	6	Ezh2 is a mediator of ews/ flil driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad Sci U S A2009，106，13：	1
	7	EZH2 is a mediator of EWS/ FLI1 driven tumor growth and metastasis blocking endothelial and neuro-eetodermal differentiation 显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad Sci USA2009，106，13：	1
	8	EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation显示文摘	RICHTER G H PLEHM S FASAN A		0，，：	1
	9	EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad Sci USA2009，106，13：	1
	10	EZH2 is a mediator of EWS/FLII driven tumor growth andmetastasis blocking endothelial and neuro-ectodcrmal differentiation 显示文摘	Richter GH Plehm S Fasan A	2009	Proc Natl Acad2009，106，13：	1
	11	GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelie CEBPA mutations and are associ- ated with favorable prognosis显示文摘	FASAN A EDER C HAFERLACH C	2013	Leukemia2013，27，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费